Submission Details
| 510(k) Number | K252767 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 29, 2025 |
| Decision Date | January 16, 2026 |
| Days to Decision | 140 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K252767 is an FDA 510(k) clearance for the actiTENS mini, a Stimulator, Nerve, Transcutaneous, For Pain Relief (Class II — Special Controls, product code GZJ), submitted by Sublimed (Moirans, FR). The FDA issued a Cleared decision on January 16, 2026, 140 days after receiving the submission on August 29, 2025. This device falls under the Neurology review panel. Regulated under 21 CFR 882.5890.
| 510(k) Number | K252767 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 29, 2025 |
| Decision Date | January 16, 2026 |
| Days to Decision | 140 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | GZJ — Stimulator, Nerve, Transcutaneous, For Pain Relief |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.5890 |